Designing better trials for epilepsy medications: the challenge of heterogeneity

Author： Friedman Daniel   French Jacqueline A  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.10, 2013-10, pp. : 927-934

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse Short-Term Effects of Attention-Control Treatment on Hypnotizability: A Challenge in Designing Controlled Hypnosis Trials

By Koch Timothy   Lang Elvira V.   Hatsiopoulou Olga   Anderson Brad   Berbaum Kevin   Spiegel David  

International Journal of Clinical and Experimental Hypnosis, Vol. 51, Iss. 4, 2003-10 ,pp. : 357-368

Routledge Ltd

Access to resources Recommend Favorite

The challenge of recruiting people with schizophrenia to trials

By Cook Sarah   Chambers Eleni   Coleman Julie   Hart Melanie  

British Journal of General Practice, Vol. 55, Iss. 521, 2005-12 ,pp. : 965-965

Royal College of General Practitioners

Access to resources Recommend Favorite

Registration of randomized clinical trials – a challenge

By  

ACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol. 59, Iss. 8, 2015-09 ,pp. : 986-989

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 1, 2013-04 ,pp. : 24-41

Bentham Science Publishers

Access to resources Recommend Favorite

Delusions, Delirium, and Cognitive Impairment: The Challenge of Clinical Heterogeneity

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 40, Iss. 8, 1992-08 ,pp. : 848-849

John Wiley & Sons Inc

Access to resources Recommend Favorite